Yunsheng Yang | Inflammatory Bowel Disease | Best Researcher Award

Posted on by Pencis

Prof. Dr. Yunsheng Yang | Inflammatory Bowel Disease | Best Researcher Award

The First Medical Center, Chinese PLA General Hospital | China

AUTHOR PROFILE

ORCID ID

🌟YUNSHENG YANG, M.D. – A LEADER IN GASTROENTEROLOGY 🏥

🎓EARLY ACADEMIC PURSUITS 

Dr. Yunsheng Yang earned his M.D. from the First Military Medical University in 1995, laying the foundation for his illustrious medical career. He pursued postdoctoral training at the Fourth Military Medical University in China, further honing his expertise in gastroenterology. His academic journey extended internationally with visiting scholar positions at the University of Sydney’s Westmead Hospital in 2008 and Mayo Clinic Rochester in 2014, where he gained invaluable global exposure to advanced medical practices.

👩‍🏢PROFESSIONAL ENDEAVORS 

Currently, Dr. Yang serves as the Academic Director of the Department of Gastroenterology and Hepatology at the First Medical Center, Chinese PLA General Hospital (PLAGH, 301 Hospital) in Beijing, China. His leadership extends beyond national borders, with visiting or adjunct professorships at Shenzhen University, Universitas Amoiensis, and the University of Michigan, USA.

His involvement in prestigious medical societies includes being the immediate past president of the Chinese Society of Gastroenterology and the Director of the APSDE Training Center in PLAGH since 2006. Dr. Yang actively engages with the World Gastroenterology Organization (WGO), serving as a scientific committee member and having previously contributed to the WGO Endoscopy Group and Nomination Committee.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

Dr. Yang’s clinical expertise primarily revolves around gastrointestinal (GI) disorders and therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP). His research is focused on robot-assisted endoscopy and GI microbiota, where he has pioneered multiple innovative procedures in China, including:

  • Endoscopic suturing for GERD (2001)
  • Double balloon enteroscopy (2003)
  • Peroral video cholangioscopy and laser lithotripsy (2004)
  • Confocal endomicroscopy (2006)
  • MUSE for GERD (2017)
  • Fecal Microbiota Transplantation (FMT) clinical trials for IBD, autism, and Tourette syndrome (since 2014)

Notably, he led the development of the YunSRobot, a robot-assisted GI endoscopy system, successfully performing gastroscopy on human volunteers in 2017 and completing remote gastroscopy in 2021. These groundbreaking achievements have been published and indexed in PubMed.

📚IMPACT AND INFLUENCE 

Dr. Yang’s influence in the field of gastroenterology is reflected in his extensive publication record. He has authored over 200 articles in Chinese journals and more than 150 papers in international SCI-indexed journals, including prestigious titles such as Gastroenterology, Hepatology, The American Journal of Gastroenterology (AJG), Gastrointestinal Endoscopy (GIE), Alimentary Pharmacology & Therapeutics (AP&T), and Gut.

As an editorial board member for Gut and AP&T, and associate editor for MMR and JDD, he continues to shape the direction of gastroenterology research and clinical practice worldwide.

🌟ACADEMIC CITES AND RECOGNITION 

Dr. Yang’s research contributions have been extensively cited by peers in the medical and scientific communities. His innovations in endoscopic procedures and gastrointestinal microbiota research have influenced treatment protocols and technological advancements in digestive health worldwide. His pioneering work on FMT for neurological conditions and robotic-assisted endoscopy is setting new standards in precision medicine.

💪LEGACY AND FUTURE CONTRIBUTIONS 

Dr. Yang’s enduring legacy lies in his transformative impact on gastroenterology, blending cutting-edge technology with clinical expertise. His leadership in developing robotic-assisted endoscopy has the potential to revolutionize non-invasive diagnostics and treatment, paving the way for AI-integrated endoscopic procedures.

Looking ahead, Dr. Yang continues to push the boundaries of GI research, particularly in the integration of robotics, microbiota-based therapies, and novel endoscopic interventions. His mentorship of young gastroenterologists ensures a lasting impact on the field, fostering the next generation of leaders in digestive health research and clinical innovation.

🌍CONCLUSION 

Dr. Yunsheng Yang stands as a trailblazer in the field of gastroenterology, with his extensive contributions in clinical practice, research, and technological innovation. His groundbreaking advancements in robot-assisted endoscopy and GI microbiota research have set new benchmarks in the medical field. His dedication to patient care, scientific discovery, and mentorship ensures his influence will resonate for years to come, shaping the future of digestive health worldwide.

 

📊🔬NOTABLE PUBLICATION:
  1. Title: Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis.
    Authors: Yan J, Chen H, Zhang Y, Peng L, Wang Z, Lan X, Yu S, Yang Y.
    Year: 2024

 

  1. Title: Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
    Authors: Chen J, Zhang Y, Min H, Zhi J, Ma S, Dong H, Yan J, Chi X, Zhang X, Yang Y.
    Year: 2024

 

  1. Title: Colorectal cancer and gut microbiota studies in China.
    Authors: Wang Z, Dan W, Zhang N, Fang J, Yang Y.
    Year: 2023

 

  1. Title: The fecal microbiota from children with autism impact gut metabolism and learning and memory abilities of honeybees.
    Authors: Li Y, Zhang Y, Luo X, Meng Y, Zhong Z, Zheng H, Yang Y.
    Year: 2023

 

  1. Title: Deep insights into the gut microbial community of extreme longevity in South Chinese centenarians by ultra-deep metagenomics and large-scale culturomics.
    Authors: Li C, Luan Z, Zhao Y, Chen J, Yang Y, Wang C, Jing Y, Qi S, Li Z, Guo H, et al.
    Year: 2022

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

Posted on by Pencis

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

University of Nouakchott | Mauritania

Author Profile

Scopus

ORCID ID

Dr. Mohamed Lemine Cheikh Brahim Ahmed

🎓Education :

  • PhD in Public Health 🧬
    Université Mohammed V, Rabat, Morocco
  • Master of Public Health in Molecular Epidemiology of Zoonotic Diseases 🦠🔬
    IAV Hassan II, Rabat, Morocco
  • Certificate in Molecular Biology and Bioinformatics 🧬💻
    Hua Zhong Normal University, Wuhan, China

🌍Professional Memberships :

  • Member of the World Society for Virology (WSV) 🧫
  • Member of the International Covid-19 Research Network (ICRN) 🦠
  • Member of the One Health Heukelbach Institute 🌱
  • Member of the MENA Coalition for HPV Elimination 💉
  • Member of the Research Unit on Molecular Epidemiology and Microorganism Diversity (EMDM) 🧬
  • President of the Mauritanian Society for Scientific Research (AMDRS) 🧑‍🔬
  • Collaborator on the Global Burden of Diseases (GBD) project, Institute for Health Metrics and Evaluation, University of Washington 🌎

💡Key Skills :

  • Vaccine Coordination & Logistics 🚚💉:

  • Planned and supervised vaccine logistics for remote regions in Mauritania, ensuring stock management and quality control practices for vaccines like PCV13 and Rotarix.

  • Public Health Communication & Training 📢👩‍⚕️:

  • Conducted team-building and training sessions for local health personnel, focusing on routine and Covid-19 vaccination campaigns.

  • Research Project Management 🧑‍🔬📊:

  • Led public health research projects, managing performance indicators, and reporting on vaccine distribution and health systems.

  • Flexibility & Versatility ⚙️:

  • Adapted to various challenges in vaccine distribution and epidemiological surveillance, especially during pandemics.

✅Main Qualifications :

Vaccination 💉:

  • Supervised and trained local teams for stock management and quality control of vaccines across remote areas in Mauritania.
  • Led national Covid-19 vaccination strategy development, training teams and evaluating the impact of vaccine introductions (e.g., PCV13, Rotarix).
  • Coordinated routine vaccination campaigns across all 15 regions of Mauritania and introduced critical vaccines like nVPO2 for polio.

Epidemiological Surveillance 🧬:

  • Developed and implemented national strategies for combatting Covid-19, including plans for testing diseases like measles, polio, hemorrhagic fevers, and HPV.
  • Organized and led sentinel surveillance programs for diseases like rotavirus and influenza.
  • Conducted performance evaluations of Mauritania’s health information systems and trained response teams for integrated epidemiological surveillance.

🏢Recent Professional Experience :

National Consultant

UNICEF, Mauritania (Feb 2022 – Jul 2022)
Supported cold chain logistics and vaccine management for poliomyelitis response campaigns. Key tasks included overseeing vaccine distribution, supporting data analysis, and participating in meetings for budget planning with GPEI.

  • Provided technical assistance for vaccine logistics, ensuring the collection and destruction of unusable vaccine vials.
  • Led training sessions for independent monitors and LQAS surveyors to evaluate the polio vaccination campaign.

📈 Conclusion🌟

Dr. Mohamed Lemine Cheikh Brahim Ahmed is a highly skilled expert in vaccination logistics and epidemiological surveillance 🦠💉, with extensive experience in public health, research management, and disease control. His work spans from developing national vaccination strategies, including Covid-19, to training teams and overseeing campaigns in remote regions of Mauritania. As a member of numerous global health organizations 🌍 and a key contributor to projects like the Global Burden of Diseases 🌎, he is committed to improving public health outcomes through innovative approaches and evidence-based strategies. Dr. Ahmed’s versatility, leadership, and dedication make him a valuable asset in the field of global health and vaccination efforts.

📊🔬NOTABLE PUBLICATION:

 

    • Article: Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis
      • Authors: Abou Ghayda, R., Lee, K.H., Han, Y.J., Smith, L., Shin, J.I.
      • Journal: Journal of Medical Virology
      • Year: 2022

     

    • Article: Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
      • Authors: Park, S.H., Hong, S.H., Kim, K., Il Shin, J., Smith, L.
      • Journal: Journal of Medical Virology
      • Year: 2023

     

    • Article: COVID-19 outbreak in Mauritania: Epidemiology and health system response
      • Authors: Ahmed, M.L.C.B., Zehaf, S., El Alem, M.M., Abdellahi, M.V.M., Heukelbach, J.
      • Journal: Journal of Infection in Developing Countries
      • Year: 2021

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

Posted on by Pencis

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

IQVIA | Netherlands 

Author Profile

Scopus

🌍Mrs. Anke van Engen 💼

  • Managing Principal, IQVIA Payer Evidence Solutions
    Amsterdam, the Netherlands

🔬Profile:

  • Anke van Engen is a seasoned expert with over 20 years of experience in health economics, outcomes research, and market access strategy. Her work focuses on helping life sciences companies achieve greater commercial success through integrated payer evidence strategies. Anke is well-regarded for building lasting partnerships, consistently delivering results, and serving as a trusted advisor to clients. She excels at leading international teams across EMEA, using her coaching and training abilities to inspire success.

👨‍⚕️Key Specialties:

  • 📚General management
  • 🌍Strategic planning & business development
  • 🩺Health economics & outcomes research (HEOR)
  • 🏥Market access strategy (MA) & execution
  • 💉Health technology assessment (HTA)
  • 📍Client relationship management & coaching

💼Professional Experience:

  • 🌟2023 – Present: Managing Principal, IQVIA Value & Payer Evidence
    • Co-leads EMEA Real World Evidence Leadership Team
    • Oversees integrated evidence & EU HTA offerings
  • 💡2020 – 2023: Senior Principal, IQVIA Real World Solutions
    • Led the development of EMEA payer evidence solutions
    • Drove go-to-market strategy and key client partnerships
  • 🌐2017 – 2020: Senior Principal, IQVIA Consulting Services
    • Managed partnerships with large pharmaceutical clients
    • Led the HTA Accelerator solution for launch readiness
  • 🚀2014 – 2017: Principal, Quintiles Advisory Services
    • Led development of the flagship HTA Accelerator platform
    • Senior oversight on HEOR/MA strategy and projects

🎓Education:

  • 🧪MSc in Chemistry (Bio-organic Chemistry), University of Leiden, The Netherlands
  • 📊Business leadership programs at IMD, Lausanne, Switzerland

🌐Professional Affiliations:

  • 🧬Active member of ISPOR and HTAi
  • 💡IQVIA representative at GetReal Institute

🏅Awards & Honors:

  • 🌟2023: Issue panel ranked #1 at ISPOR Europe
  • 🦈2014: Won Sharktank contest for HTA Accelerator innovation
  • 🏆Multiple ISPOR awards for best podium and poster presentations

 

🔍 Conclusion
  • 💼In conclusion, Anke van Engen is a highly respected leader in the field of health economics, outcomes research, and market access strategy, with a proven track record of guiding life sciences companies toward commercial success. Her expertise in building long-term client partnerships, managing international teams, and delivering innovative payer evidence solutions has solidified her reputation as a trusted advisor. With over two decades of experience and numerous accolades, Anke continues to shape the future of healthcare consultancy by integrating strategic insights and real-world evidence. 🌍

 

📊🔬NOTABLE PUBLICATION:

 

    • The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment
      • Authors: van Engen A, Krüger R, Parnaby A, Rotaru M, Ryan J, Samaha D, Tzelis D
      • Journal: Value Health
      • Year: 2024

     

    • Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials
      • Authors: Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J
      • Journal: Value Health
      • Year: 2021

     

    • Call in the PROs: Giving Credence to the Patient’s Perspective in Healthcare Decision Making
      • Authors: van Engen A, New M, Beatrice Böhler Y, Holmstrom S, Boerlum Kristensen F
      • Journal: ISPOR Value & Outcomes Spotlight
      • Year: 2020

Assist Prof Dr. Zixing Wang | Epidemiology | Best Researcher Award

Posted on by Pencis

Assist Prof Dr. Zixing Wang | Epidemiology | Best Researcher Award

Peking University People’s Hospital | China

AUTHOR PROFILE

Scopus

 

🌿ASSIST PROF DR. ZIXING WANG 🌿

📘EDUCATION

  1. 🎓 Ph.D. in Epidemiology and Biostatistics
    Peking Union Medical College (2013-09 to 2019-07)
  2. 📜 Bachelor’s Degree in Preventive Medicine
    Hebei Medical University (2008-09 to 2013-07)

🧪EARLY ACADEMIC PURSUITS

Zixing Wang embarked on his academic journey with a Bachelor’s degree in Preventive Medicine from Hebei Medical University, where he developed a strong foundation in public health and disease prevention. He then pursued a Ph.D. in Epidemiology and Biostatistics at Peking Union Medical College, deepening his expertise in statistical methods and epidemiological research.

🔬PROFESSIONAL ENDEAVORS

Zixing Wang’s professional career began as an Assistant Researcher at the Chinese Academy of Medical Sciences, where he served from August 2019 to July 2022. He was then promoted to Associate Researcher at the same institution, a role he held until February 2024. Currently, he is an Assistant Professor at Peking University and an Associate Researcher at Peking University People’s Hospital, positions he has held since March 2024.

📊 CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY

Wang’s research primarily focuses on the application of machine learning in medical imaging and predictive modeling for diseases. He has led multiple significant projects, including those funded by the National Natural Science Foundation of China and Peking Union Medical College Hospital. His notable projects include:

  1. 📊 Recognition of Lung Nodule Evolution Patterns Based on Delta Imaging Omics and Dynamic Decision-making for Follow-up Timing (2024-01-01 to 2026-12-31)
  2. 🧠 Study on Prediction Model of Female Urinary Incontinence Outcome Based on Machine Learning (2022-07 to 2024-12)
  3. 🩺 Establishment of HRCT Features and Evaluation System for Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease Using Deep Learning (2022-07 to 2024-12)
  4. 🤖 Exploration of Reinforcement Learning Methods for Individualized Follow-up Timing Schemes for Lung Nodule Patients (2021-01 to 2022-12)
  5. 🔬 Research on Gradient Boosting Algorithm for Discrimination Diagnosis of Lung Cancer Based on Dual-energy CT Fractal Dimension (2016-10 to 2018-10)

🩺IMPACT AND INFLUENCE

Wang’s research has significantly impacted the fields of epidemiology and biostatistics, particularly in the use of advanced imaging techniques and machine learning for disease prediction and diagnosis. His work on lung nodule evolution patterns and predictive models for urinary incontinence and interstitial lung disease has advanced clinical practices and decision-making processes.

📚ACADEMIC CITES

Zixing Wang has an extensive list of publications in high-impact journals, contributing to his recognition and citation in the academic community. His work is frequently cited by peers, reflecting the influence and relevance of his research in the scientific field.

👩‍🔬LEGACY AND FUTURE CONTRIBUTIONS

Wang’s legacy lies in his pioneering research and the development of innovative methodologies in medical imaging and disease prediction. As he continues his work at Peking University and Peking University People’s Hospital, his future contributions are expected to further advance the field of epidemiology and biostatistics, particularly through the integration of machine learning and artificial intelligence in medical research.

📜OTHER IMPORTANT TOPICS

🌟GRANTS AND PROJECT FUNDING Wang has successfully secured funding for numerous research projects, demonstrating his capability to lead and manage large-scale studies. His ability to obtain grants from prestigious institutions underscores the significance and potential impact of his research.

🏆TEACHING AND MENTORSHIP In his role as an Assistant Professor, Wang is committed to educating the next generation of researchers. He actively mentors students, guiding them in their academic and research pursuits, and fostering a collaborative and innovative learning environment.

🏢INTERDISCIPLINARY COLLABORATIONS Wang collaborates with experts across various disciplines, enhancing the interdisciplinary nature of his research. These collaborations enable the integration of diverse perspectives and expertise, contributing to the robustness and applicability of his findings.

By highlighting Zixing Wang’s comprehensive academic journey, professional achievements, and impactful contributions, this resume encapsulates his significant role in advancing the fields of epidemiology and biostatistics. His continued dedication to research and education promises a lasting legacy and future innovations in medical science

 

📊🔬Notable Publication:

 

Prevalence and Patterns of Multimorbidity in China During 2002–2022: A Systematic Review and Meta-Analysis

  • Authors: Hu, Y., Wang, Z., He, H., …, Tu, J., Shan, G.
    Journal: Ageing Research Reviews
  • Year: 2024

Spatial Association of Surface Water Quality and Human Cancer in China

  • Authors: Wang, Z., Gu, W., Guo, X., …, Du, J., Jiang, J.
    Journal: npj Clean Water
  • Year: 2023

Assessment of the Spatial Association Between Multiple Pollutants of Surface Water and Digestive Cancer Incidence in China: A Novel Application of Spatial Machine Learning

  • Authors: Gu, W., Xue, F., Han, W., …, Yang, C., Jiang, J.
    Journal: Ecological Indicators
  • Year: 2023

Prognostic and Predictive Value of Interstitial Lung Abnormalities and EGFR Mutation Status in Patients with Non-Small Cell Lung Cancer

  • Authors: Xu, X., Zhu, M., Wang, Z., …, Zhang, Y., Gao, Y.L.
    Journal:Cancer Imaging
  • Year: 2024

Reinforcement Learning for Individualized Lung Cancer Screening Schedules: A Nested Case–Control Study

  • Authors: Wang, Z., Sui, X., Song, W., …, Hu, Y., Jiang, J.
    Journal: Cancer Medicine
  • Year: 2024